Outcome of radiotherapy in T1 glottic carcinoma: a population-based study

Eur Arch Otorhinolaryngol. 2009 May;266(5):735-44. doi: 10.1007/s00405-008-0803-9. Epub 2008 Oct 7.

Abstract

We evaluated the radiation outcome and prognostic factors in a population-based study of early (T1N0M0) glottic carcinoma. Survival parameters and prognostic factors were evaluated by uni- and multivariate analysis in 316 consecutive irradiated patients with T1 glottic carcinoma in the Comprehensive Cancer Center West region of the western Netherlands. Median follow-up was 70 months (range 1-190 months). Five and ten-year local control was 86 and 84%. Disease specific survival was 97% at 5 and 10 years. In multivariate analysis, pre-existent laryngeal hypertrophic laryngitis was the only predictive factor for local control (relative risk = 3.0, P = 0.02). Comorbidity was prognostic for overall survival. No factor was predictive for disease specific survival. Pre-existent laryngeal hypertrophic laryngitis is a new risk factor associated with reduced local control in T1 glottic carcinoma treated with radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / epidemiology
  • Carcinoma / pathology*
  • Carcinoma / radiotherapy*
  • Female
  • Follow-Up Studies
  • Glottis / pathology*
  • Glottis / radiation effects*
  • Humans
  • Hypertrophy / pathology
  • Laryngeal Neoplasms / epidemiology
  • Laryngeal Neoplasms / pathology*
  • Laryngeal Neoplasms / radiotherapy*
  • Laryngitis / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Population Surveillance / methods
  • Predictive Value of Tests
  • Preoperative Care
  • Survival Rate